Nona Tepper

UnitedHealthcare and TeamHealth have a history of suing one another.

Doctors say they need to be paid for their time spent sending patient messages through portals such as Epic Systems' MyChart. But payers and patient advocates worry about the impact such charges would have on access and overall costs.

Blue Cross and Blue Shield of Illinois won't cover gender-affirming care for a teenager covered by a Catholic health system's self-funded employee health plan. The insurer  now faces a class-action lawsuit alleging it violated federal anti-discrimination law.

The Justice Department sued to block the deal in February, alleging it would violate antitrust law by giving UnitedHealth Group's insurance arm access to intelligence about how rival insurers structure their provider networks.

The Louisiana Municipal Risk Management Agency sued TeamHealth, alleging the physician staffing firm overcharged for services. But a federal judge has dismissed the case.

The divestiture of Magellan Specialty Health is part of Centene's ongoing value creation plan. 

OptumRx is the first pharmacy benefit manager to disclose how it plans to deal with Humira ahead of lower-cost rivals to the pricey drug that enter the market next year.

At least 17 Blues plans now offer at least one prescription digital therapeutic from vendors such as Akili Interactive, Pear Therapeutics and Big Health as a standard benefit for some members.

Providers have been slow to adopt the Clover Assistant tool,  so the insurtech hopes to boost the product by providing its Medicare Advantage members a $150 incentive to seek out those who do.

Bright Health Group will end its Medicare Advantage operations in Florida as it continues its pursuit of profitability next year. 

Elevance Health plans to incorporate BioPlus into its IngenioRx pharmacy benefit manager and expects the deal to close in the first half of 2023. 

The health insurance company suffered a $193.5 million net loss during the third quarter, it disclosed to investors Tuesday.

The competition is heating up for insurance companies seeking Medicare Advantage plan members—but so is federal agency oversight.

Dr. Kirsten Bibbins-Domingo, editor-in-chief of the Journal of the American Medical Association and the JAMA Network, discusses how scientific findings can counter misinformation and the importance of understanding those with different perspectives. 

The move will result in an estimated $1 billion decline in revenue next year.